Novo CEO pressed by Senate to cut costs of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would think about new talks with insurers regarding the listing prices of Wegovy and copyright if they pledge to keep the medicines on their own formularies. Pay attention https://donovantkaqh.blogs-service.com/61618592/the-healthcare-news-diaries